Table 2 Major health care services and resource utilization

Antibiotics; n (%)

85(61.59)

43(97.73)

42(44.68)

< 0.001**

 Co-trimoxazole suspension 40 mg/200 mg per 5 ml

37(26.81)

36(81.82)

1(1.06)

< 0.001**

 Ampicillin injection 1 g

27(19.57)

0(0.0)

27(28.72)

< 0.001**

 Gentamicin injection 1 vial 80 mg

14(10.14)

0(0.0)

14(14.89)

0.005**

 Metronidazole syrup 125 mg 100 ml

14(10.14)

10(22.73)

4(4.26)

0.002****

 Amoxicillin syrup 125 mg/5 ml

10(7.25)

4(9.09)

6(6.38)

0.726****

 Cefotaxime injection 1 g IM/IV

7(5.07)

0(0.0)

7(7.45)

0.097****

 Metronidazole injection .500 mg/100 ml

7(5.07)

0(0.0)

7(7.45)

0.097****

Laboratory tests (%)

93(67.39)

30(68.18)

63(67.21)

0.892**

 Full blood count

60(43.48)

0(0.0)

60(63.83)

< 0.001**

 C-reactive protein (CRP)

56(40.58)

0(0.0)

56(59.57)

< 0.001**

 Thick blood smear

56(40.58)

5(11.36)

51(54.26)

< 0.001**

 Stool microscopy

33(23.91)

24(54.55)

9(9.57)

< 0.001**

 Malaria rapid test

15(10.87)

15(34.09)

0(0.0)

< 0.001**

Ringer lactate 500 ml

60(43.48)

0(0.0)

60(63.83)

< 0.001**

Paracetamol syrup 120 mg/5 ml

28(20.29)

27(61.36)

1(1.06)

< 0.001**

ORS

37(26.81)

33(75.00)

4(4.26)

< 0.001**

Zinc sulfate 20 mg tablet

41(29.71)

32(72.73)

9(9.57)

< 0.001**

Length of stay (day) ^a; mean

(SD), median

8.90

(3.6),9.0

n/a

8.90

(3.6),9.0

n/a

Treatment before visit or admission; n (%)

51(36.96)

6 (13.64)

45 (47.87)

< 0.001**

Treatment after admission/visit; n (%)

7 (5.07)

0 (0.0)

7 (7.45)

0.097****

Caregiver’s time loss (day); mean

(SD), median

7.45 (8.91),4

2.72 (1.89),2

9.66 (9.98),5

< 0.001***